BioLife Solutions, Inc.

Total Valuation

BioLife Solutions, Inc. carries a market capitalization of 1.71B, placing it among publicly traded companies globally. Its enterprise value stands at 1.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

BioLife Solutions, Inc. currently has 48.83M shares outstanding.

Valuation Ratios

BioLife Solutions, Inc. trades at a trailing price-to-earnings ratio of 23.55. The price-to-sales ratio is 13.28, and the price-to-book ratio stands at 3.28.

Enterprise Valuation

On an enterprise value basis, BioLife Solutions, Inc. trades at an EV/EBITDA multiple of 204.70 and an EV/FCF ratio of 51.16. The EV/Sales ratio of 12.76 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 440.17 provides insight into valuation relative to core operating earnings.

Financial Position

BioLife Solutions, Inc. maintains a current ratio of 9.69, meaning it holds 9.7x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Taxes

Over the trailing twelve months, BioLife Solutions, Inc. has paid -42.38M in income taxes, reflecting an effective tax rate of 16.63.

Stock Price Statistics

BioLife Solutions, Inc.'s stock has gained approximately 44.08381% over the past 52 weeks. The 50-day moving average sits at 29.38, while the 200-day moving average is 24.70.

Income Statement

Over the trailing twelve months, BioLife Solutions, Inc. generated 102.82M in revenue and converted that into 57.98M in net income, yielding earnings per share of 1.03. EBITDA reached 6.41M, while operating income came in at 2.98M.

Balance Sheet

BioLife Solutions, Inc. holds 82.42M in cash and equivalents against 15.74M in total debt, resulting in a net debt position of -24.00M. Total book value stands at 420.00M, with working capital of 121.25M providing operational flexibility.

Cash Flow

BioLife Solutions, Inc. produced 16.88M in operating cash flow over the past twelve months. After subtracting -8.77M in capital expenditures, free cash flow totaled 8.11M - equivalent to 0.17 per share.

Margins

BioLife Solutions, Inc. operates with a gross margin of 63.88, reflecting its pricing power and cost economics. The operating margin of 2.90 and net profit margin of 56.39 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

BioLife Solutions, Inc.'s most recent stock split took place on January 29, 2014 with a 14:1 split ratio.

Scores

BioLife Solutions, Inc. posts an Altman Z-Score of 29.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.